Yuan Xie

National Institutes of Pharmaceutical Research and Development (China) — China

Medicine · Health Sciences

23h-index1.8kcitations90works3.42yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Head and Neck Cancer Studies(9), Pharmacogenetics and Drug Metabolism(7), Lung Cancer Treatments and Mutations(7), Cancer-related molecular mechanisms research(7), Drug-Induced Hepatotoxicity and Protection(7)

Publications89 total

c-Myc-PANK3-EMT axis regulates the structure and function of intestinal barrier in ulcerative colitis

Journal of Advanced Research·2025Open Access

Study of the machine learning emission inversion method of the CUACE model on the basis of fused Fengyun observations

Atmospheric Pollution Research·2025

Efficacy and Safety of Vascular-Targeting Agents Plus Chemotherapy Versus Chemotherapy Alone in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients: A Multicenter Clinical Cohort Study

Cancer Control·2025Open Access

LBA78 KN026 in combination with chemotherapy for previously treated HER2-positive gastric or gastroesophageal carcinomas (GC/GEJC): Interim analysis of KC-WISE

Annals of Oncology·2025Open Access

Author response for "Efficacy and Safety of Vascular-Targeting Agents Plus Chemotherapy Versus Chemotherapy Alone in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients: A Multicenter Clinical Cohort Study"

2025

The impact of the COVID-19 epidemic on anthropogenic emissions in the Beijing-Tianjin-Hebei region of China based on 3DVar sectoral emission inversion

Journal of Hazardous Materials·2025

Influence of <scp>COVID</scp>‐19 Vaccination on Treatment‐Related Adverse Events and Oncologic Outcomes of Nonmetastatic Nasopharyngeal Carcinoma

Head & Neck·2025Open Access

The role of GOT1 in cancer metabolism

11 cited

Frontiers in Oncology·2024· 11 citedOpen Access

385P Establishment of a prognostic model for endometrial cancer using CRISPR and machine learning, and identification of the key gene PLK1

Annals of Oncology·2024Open Access

Integrated analyses of multi-omic data derived from paired primary lung cancer and brain metastasis reveal the metabolic vulnerability as a novel therapeutic target

23 cited

Genome Medicine·2024· 23 citedOpen Access

Effect of the mRNA decapping enzyme scavenger (DCPS) inhibitor RG3039 on glioblastoma

2 cited

Journal of Translational Medicine·2024· 2 citedOpen Access

An individualized immune prognostic signature in nasopharyngeal carcinoma

1 cited

Oral Oncology·2024· 1 cited

Initiator cell death event induced by SARS-CoV-2 in the human airway epithelium

UNC Libraries·2024Open Access

Journal of Investigative Dermatology·2024Open Access

Influence of COVID-19 Vaccination on Treatment-Related Adverse Events and Oncologic Outcomes of Non-metastatic Nasopharyngeal Carcinoma

2024Open Access

Identification of prognostic biomarkers for endometrioid endometrial carcinoma based on the miRNA and mRNA co‐expression network regulated by estradiol

2024Open Access

Efficacy and safety of vascular-targeting agents plus chemotherapy versus chemotherapy alone in recurrent or metastatic nasopharyngeal carcinoma patients：A multicenter observational clinical trial

Research Square (Research Square)·2024Open Access

Induction Chemotherapy Followed by Radiotherapy vs Chemoradiotherapy in Nasopharyngeal Carcinoma

31 cited

JAMA Oncology·2024· 31 citedOpen Access

Integrated Analyses of Multi-omic Data Derived from Paired Primary Lung Cancer and Brain Metastasis Reveals the Metabolic Vulnerability as a Novel Therapeutic Target

2024Open Access

page 1 of 5Next →

Frequent Co-authors

Guangji Wang(25), Jiye Aa(11), Runbin Sun(9), Haiping Hao(8), Haitao Zhao(6), Kang An(6), Jianzhen Lin(5), Xueshuai Wan(5), Xinting Sang(5), Tong Xie(5), Lin Xie(5), Jiye Aa(5), Hong Wang(5), Siqi Feng(5), Anqiang Wang(4), Liangcai Wu(4), Xiaobo Yang(4), Na Yang(4), Haohai Zhang(3), Yan Liang(3)